EXEL insider ownership: SVP & General Counsel discloses share holdings
Rhea-AI Filing Summary
Exelixis, Inc. officer reports beneficial ownership of company stock. The SVP and General Counsel is shown as beneficially owning 90,441 shares of Exelixis common stock directly, including 80,575 shares that will be issued upon vesting of restricted stock units and performance-based restricted stock units, and 556 shares acquired under the company’s 2000 Employee Stock Purchase Plan. In addition, 5,527 shares are held indirectly through the Exelixis 401(k) Plan as of November 7, 2025.
Positive
- None.
Negative
- None.
FAQ
How many Exelixis (EXEL) shares does the SVP and General Counsel beneficially own directly?
The SVP and General Counsel is reported as directly beneficially owning 90,441 shares of Exelixis common stock. This figure includes shares underlying restricted stock units and performance-based restricted stock units, as well as shares acquired under the employee stock purchase plan.
What portion of the Exelixis (EXEL) holdings are in RSUs and PSUs for this officer?
The filing states that 80,575 shares of Exelixis common stock will be issued upon vesting of restricted stock units (RSUs) and performance-based restricted stock units (PSUs), and these are included in the reported direct beneficial ownership.
How many Exelixis (EXEL) shares were acquired under the Employee Stock Purchase Plan?
The officer’s direct holdings include 556 shares of Exelixis common stock that were acquired under the Exelixis, Inc. 2000 Employee Stock Purchase Plan.
How many Exelixis (EXEL) shares does the officer hold indirectly through the 401(k) Plan?
The officer is reported as indirectly beneficially owning 5,527 shares of Exelixis common stock through the Exelixis, Inc. 401(k) Plan, based on a plan statement dated November 7, 2025.
What is the officer’s role and relationship to Exelixis (EXEL)?
The reporting person is identified as an officer of Exelixis, Inc., serving as SVP and General Counsel, and the filing reports this individual’s beneficial ownership of Exelixis common stock.
Does the filing include any derivative securities for the Exelixis (EXEL) officer?
The section for derivative securities is presented, but in the provided content there are no specific derivative securities listed with dates, exercise prices, or share amounts.